Alert: New Earnings Report (2/28/24)-ADMA Biologics Inc (NASDAQ: ADMA).
For its fourth fiscal quarter (ending December 31), ADMA Biologics Inc (NASDAQ: ADMA) has reported E.P.S. of $-0.08 compared to $-0.06 a year ago. This performance was $-0.09 short of the consensus estimate of $0.01. […]